Literature DB >> 11431760

Severe blunt hepatic trauma in children.

J P Pryor1, P W Stafford, M L Nance.   

Abstract

BACKGROUND: Severe blunt hepatic injury in children is associated with a high mortality rate. Although nonoperative management has become the treatment of choice for mild to moderate liver trauma, there is no consensus as to the optimal treatment for the most severe hepatic injuries in children.
METHODS: A statewide trauma registry was reviewed to identify children (age 18 years or less) treated for a severe blunt liver injury for the period 1993 to 1998. Only children with an American Association for the Surgery of Trauma grade V (AIS code 541828.5) liver injury were included. Database records were reviewed for demographic information, associated injuries, survival rate, length of stay (LOS), intensive care days (ICUD), and treatment rendered after resuscitation in the emergency department.
RESULTS: Thirty children with a grade V liver injury were identified. The mean age was 11.2 years (range, 1 to 18), and the overall survival rate was 56%. Data for 5 patients were excluded (4 patients died in the emergency department, and 1 patient was transferred to another institution after arrival). Survivors had a trend toward a lower injury severity score (ISS) (36.1 v 44.6; P <.1) and a significantly higher Glasgow Coma Scale (GCS), 12.5 v 6.6; P <.007). Patients with a decreased GCS had a lower overall survival rate (GCS < 8, 30% v GCS > 8, 76%). In the subset of 14 patients taken directly to the operating room, there was no difference between survivors (n = 6, 43%) and nonsurvivors (n = 8, 57%) in ISS (43 v 43; P value, not significant) or GCS (8.6 v 8.0; P value, not significant). Of the 11 patients treated nonoperatively, 10 (91%) survived with an average ISS of 33 and GCS of 13.8. Nonsurvivors more often had identified associated injuries to other abdominal and retroperitoneal organs.
CONCLUSIONS: Severe hepatic injury is associated with a very high overall mortality rate in children. A low GCS is associated with a significant decrease in survival rate and may be the most important factor in outcome. Patients taken directly to the operating room have a slightly greater injury severity and a decreased survival rate compared with those treated nonoperatively. Thresholds and indications for laparotomy in these patients are not clear, and the need for operative management should be guided by the child's physiologic response to resuscitation. For those patients whose physiologic response to resuscitation permitted nonoperative management, a good outcome was achieved. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2001        PMID: 11431760     DOI: 10.1053/jpsu.2001.24720

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Blunt liver trauma in children.

Authors:  Barbara Schmidt; Günther Schimpl; Michael E Höllwarth
Journal:  Pediatr Surg Int       Date:  2004-10-01       Impact factor: 1.827

2.  Surgical intervention for paediatric liver injuries is almost history - a 12-year cohort from a major Scandinavian trauma centre.

Authors:  Tomohide Koyama; Jorunn Skattum; Peder Engelsen; Torsten Eken; Christine Gaarder; Pål Aksel Naess
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-11-29       Impact factor: 2.953

Review 3.  Systematic Review of the Management of Retro-Hepatic Inferior Vena Cava Injuries.

Authors:  David Zargaran; Alexander Zargaran; Mansoor Khan
Journal:  Open Access Emerg Med       Date:  2020-06-26

4.  Management of blunt hepatic and splenic trauma in children.

Authors:  Stanley Crankson
Journal:  Ann Saudi Med       Date:  2005 Nov-Dec       Impact factor: 1.526

5.  Multiple injuries in vital organs in a child from a gunshot: a case report.

Authors:  Nikolaos Katzilakis; Michalis Michalakis; John Vlachakis; John Arbiros; Efrosyni Vassilaki; John Germanakis; Emmanuel Velivassakis; Nikolaos Rikos; Anna Maria Spanaki; George Briassoulis
Journal:  Cases J       Date:  2009-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.